Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
about
Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Phage therapy of pulmonary infectionsBacteriophages and phage-derived proteins--application approachesStrain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of InfectionBacteriophages and Their Immunological Applications against Infectious Threats.Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of BacteremiaCharacterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolatesAtomic force microscopy analysis of the Acinetobacter baumannii bacteriophage AP22 lytic cycle.Detection and quantification of Flavobacterium psychrophilum-specific bacteriophages in vivo in rainbow trout upon oral administration: implications for disease control in aquaculture.Isolation and characterization of a "phiKMV-like" bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia.Interaction of graphene family materials with Listeria monocytogenes and Salmonella enterica.A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.Advances in phage display technology for drug discovery.The role of regulated clinical trials in the development of bacteriophage therapeutics.Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestineComplete Genome Sequence of the Streptococcus suis Temperate Bacteriophage ϕNJ2.Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.Microneedle-mediated transdermal bacteriophage delivery.Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine.Antibacterial bioagents based on principles of bacteriophage biology: an overview.Phage therapy: eco-physiological pharmacology.Phage approved in food, why not as a therapeutic?Bacteriophage secondary infection.Polymicrobial Biofilm Studies: From Basic Science to Biofilm Control.Phage Therapy: Future Inquiries.Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.Delivering phage therapy per os: benefits and barriers.Novel approaches to the treatment of bacterial biofilm infections.The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages.Pseudomonas predators: understanding and exploiting phage-host interactions.Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae.Characterization of vB_SauM-fRuSau02, a Twort-Like Bacteriophage Isolated from a Therapeutic Phage Cocktail.Bacteriophages: The possible solution to treat pathogenic bacteria.Physiological and Molecular Characterization of Salmonella Bacteriophages Previously Used in Phage Therapy.Microencapsulation with alginate/CaCO3: A strategy for improved phage therapy.Complete Genome Sequence of Lytic Bacteriophage LZ35 Infecting Acinetobacter baumannii Isolates.The Presence of Two Receptor-Binding Proteins Contributes to the Wide Host Range of Staphylococcal Twort-Like Phages.Bacteriophages infecting Propionibacterium acnes.Isolation and characterization of a T4-like phage with a relatively wide host range within Escherichia coli.Unexploited opportunities for phage therapy.
P2860
Q24563742-7FC8E66B-FCD3-422F-B160-947825EAFB68Q26781119-426DC78F-3075-4160-BC46-3BECCE4BEA64Q28082731-38CC456C-4E50-43DD-94B8-A4B4A533D29BQ28546694-402DE6CD-1E97-462C-A7A3-F873508ACAB1Q30234522-023F0E48-D75C-4DC3-B636-31FCE76B4758Q30401003-9FAD863E-59E8-43E2-A9BA-F9C1BCFBB844Q33890690-618A12C9-9DE7-4066-B2A5-375201372847Q34448208-E53D2B66-200C-4080-90D2-939F62E76AA4Q34595583-8176632A-4E44-4AC9-82B0-ED27F745137AQ35007181-6D3BE4FC-5457-4E4B-84C3-32FDDA1DF9B0Q35033007-A00BB3C3-754E-42AE-AE60-8A5E1D406809Q35279671-AFC7EE9F-F4B8-4250-8A90-24133CCB9A96Q35614190-432E64F3-C27B-4AFB-8C6B-03F444137F61Q36135134-6CB5EA51-87EF-4033-A42E-47796AC6214CQ36396212-E6609303-7BCF-48C8-B911-6A1A72341561Q36601312-3C8E1526-2BCB-45F5-9C0F-D03F579BF495Q36676044-AA64CCD3-6D26-480C-A454-F505B471AD5CQ37187438-F45D6D99-0049-4C25-89A3-31AD43BCFEE5Q38004869-B0C5BFE0-7A9F-4AC4-9F06-B0DF496AFF82Q38165668-A4090270-79F8-43C8-B95E-08DBFF989518Q38230407-D4E16303-60FD-4DC8-A53E-E9767EEB8E1DQ38285489-69EC8F3F-5103-4BF6-94B1-560BAF53AB36Q38321117-6707AA8E-E7DA-4B4B-B77C-888175B30A2BQ38822761-17373EA7-6B2D-4C90-828D-9722C6233B76Q38911928-707AC633-236A-4FAA-8B74-62EF9279545FQ38989510-B62EA206-697A-4494-9096-5060D707A74CQ39019401-55B524B1-A945-4019-8F46-D8B73CB4F57DQ39072691-B61B30FA-7220-4BD4-B150-927F6A2E494AQ39083103-D99F2F24-97A2-4A3E-8436-AF5F4B996046Q39397651-E178FEEC-6105-4366-91BC-9EC4C1BCE370Q39696206-09161B07-C3B0-446F-A6F0-78F7BBB7F187Q40041460-461BB14E-87F5-4ABB-85BB-7E04482F778BQ40070554-1B4002B0-E20B-4DB5-A436-687C589BEFFEQ40267322-660EB619-D6BF-445D-9420-9A1A1F1C15E6Q40358982-5A655D5C-DBD8-4217-B1F1-3661C6F5FCFCQ40447425-42097411-F16B-4D1C-B761-C957D629204EQ40611544-135802DB-21F4-4477-8015-88EF6025349BQ40640644-F95A6469-2ECD-44CE-B37B-FC4CAA14C3BAQ40859694-B691BF81-3AE7-482B-B6F1-D1B9644DA88DQ40964122-8E224D1A-FD8E-4296-B4C1-425F69BE667E
P2860
Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent advances in bacteriopha ...... the success of phage therapy.
@en
Recent advances in bacteriopha ...... the success of phage therapy.
@nl
type
label
Recent advances in bacteriopha ...... the success of phage therapy.
@en
Recent advances in bacteriopha ...... the success of phage therapy.
@nl
prefLabel
Recent advances in bacteriopha ...... the success of phage therapy.
@en
Recent advances in bacteriopha ...... the success of phage therapy.
@nl
P2093
P2860
P1476
Recent advances in bacteriopha ...... the success of phage therapy.
@en
P2093
Brendan F Gilmore
Elizabeth M Ryan
Ryan F Donnelly
Sean P Gorman
P2860
P304
P356
10.1111/J.2042-7158.2011.01324.X
P577
2011-07-06T00:00:00Z